Anti CagA antibody among patients with non-cardia gastric cancer in comparison with non-ulcer dyspepsia in an area with high incidence of gastric cancer

Saudi Medical Journal

Volumn 29, Issue 11, 2008, Pages 1606-1610

  Mansour Ghanaei, Fariborz ^a   Abbasi, Roxana ^a   Joukar, Farahnaz ^a   Besharati, Sepiedeh ^a   Askari Jirhandeh, Neda ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAGA PROTEIN, HELICOBACTER PYLORI; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; SEX DIFFERENCE; STOMACH ADENOCARCINOMA; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DYSPEPSIA; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 58949104219     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku T, et al. Virulence factors of Helicobacter pylori responsible for gastric disease in Mongolian gerbil. J Exp Med 2000; 192: 1601-1610.
2. Straubinger RK, Greiter A, McDonough SP, Gerold A, Scanziani E, Soldati S, et al. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun 2003; 71: 2693-2703.
3. Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H, et al. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 2001; 276: 44856-44864.
4. Zarrilli R, Ricci V, Romano M. Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. Cell Micorobiol 1999; 1: 93-99.
5. El-Omar EM, Carrington M, Chow WH, McCollKE, Bream JH, Young HA, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412:99.
6. Montecucco C, Rappuoli R. Living dangerously: How Helicobacter pylori survive in the human stomach. Nat Rev Mol Cell Biol 2001; 2: 457-466.
7. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28.
8. Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003; 188: 272-281.
9. Chen XJ, Yan J, Shen YF. Dominant CagA/VacA genotypes and coinfection frequency of H. Pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases> Chin Med J (Engl) 2005; 118: 460-467.
10. Argent RH, Thomas RJ, Letley DP, Rittig MG, Hardie KR, Atherton JC. Functional association between the Helicobacter pylori virulence factors VacA and CagA. J Med Microbiol 2008; 57 (Pt2): 145-150.
11. Bach S, Makristathis A, Pinto A, Quina M, Rotter M, Hirschl AM. Helicobacter pylori type I strains among Austrian and Portuguese patients with gastritis, peptic ulcer or gastric cancer. Eur J Clin Microbiol Infect Dis 1998; 18: 807-810.
12. Evans DJ, Evans DG, Helicobacter pylori CagA: Analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor. Helicobacter 2001; 6: 187-198.
13. Figura N, Vindigni C, Covacci A, Presenti L, Burroni D, Vernillo R, et al. CagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: Relevance to histological damage. Gut 1998; 42: 772-778.
14. Gunn MC, Stephens JC, Stewart JA, Rathbone BJ, West KP. The significance of cagA and vaA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J Clin Pathol 1998; 51: 761-764.
15. Haas G, Karaali G, Ebermayer K, Metzger WG, Lamer S, Zimny-Arndt U, et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2002; 2: 313-324.
16. Lai YP, Yang JC, Lin TZ, Wang JT, Lin JT. CagA tyrosine phosphorylation in gastric epithelial cells caused by Helicobacter pylori in patients with gastric adenocarcinoma. Helicobacter 2003; 8: 235-243.
17. Matsukura N, Onda M, Kato S, Hasegawa H, Okawa K, Shirakawa T, et al. Cytotoxin gense of Helicobacter pylori in chronic gastritis, gastroduodenal ulcer and gastric cancer: An age and gender matched case-control study. Jpn J Cancer Res 1997; 88: 532-536.
18. Miehlke S, Yu J, Schuppler M, Frings C, Kirsch C, Negraszus N, et al. Helicobacter pylori VacA, IceA, and CagA status, and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am J Gastroenterol 2001; 96: 1008-1013.
19. Occhialini A, Marais A, Urdaci M, Sierra R, Muñoz N, Covacci A, et al. Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun 2001; 69: 1902-1908.
20. Owen RJ, Sharp SI, Chisholm SA, Rijpkema S. Identification of CagA tyrosine phosphorylation DNA motifs in Helicobacter pylori isolates from peptic ulcer patients by novel PCR-restriction fragment length polymorphism and real-time fluorescence PCR assays. J Clin Microbiol 2003; 41: 3112-3118.
21. Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, et al. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 1997; 35: 1344-1347.
22. Peters TM, Owen RJ, Slater E, Varea R, Teare EL, Saverymuttu S. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia. J Clin Pathol 2001; 54: 219-223.
23. Slater E, Owen RJ, Williams M, Pounder RE. Conservation of the cag pathogenicity island of Helicobacter pylori: Associations with vacuolating cytotoxin allele and IS605 diversity. Gastroenterology 1999; 117: 1308-1315.
24. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000. proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000; 97: 7533-7538.
25. Zhang MJ, Meng FL, Ji XY, He LH, Zhang JZ. Adherence and invasion of mouse adapted H pylori in different epithelial cell lines. World J Gastroenterol 2007; 13: 845-850.
26. Shimoyama T, Fukuda S, Tanaka M. CagA seropositivity associated with development of gastric cancer in Japanese population. J Clin Pathol 1998; 51: 225-228.
27. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig Dis Sci 2005; 50: 2075-2080.
28. Talebkhan Y, Mohammadi M, Mohagheghi MA, Vaziri HR, Eshagh Hosseini M, Mohajerani N, et al. CagA gene and protein status among Iranian Helicobacter pylori strains. Dig Dis Sci 2008; 53: 925-932.
29. Ghoshal UC, Tiwari S, Dhingra S. Pandey R. Ghoshal U, Tripathi S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: The Indian enigma. Dig Dis Sci 2008; 53: 1215-1222.
30. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 297-301.
31. Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains? Helicobacter 2004; 9: 271-277.
32. Gurbuz AK, Ozel AM, Yazgan Y, Gunay A, Ozdemir S, Demirtürk L, et al. Seropositivity against Helicobacter pylori CagA in Turkish gastric cancer patients. J Clin Gastroenterol 2001; 33: 389-392.
33. Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK, et al. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: Potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol 2008; 46: 1774-1779.
34. Yang G, Hu F, Jia J. Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases. Zhonghua Yi Xue Za Zhi 2001; 81: 648-650.
35. Grimley CE, Holder RL, Loft DE, Morris A, Nwokolo CU. Helicobacter pylori associated antibodies in patients with dudodenal ulcer, gastric ulcer, and gastric and esophageal adenocarcinoma. Eur J Gastroenterol Hepatol 1999; 11; 503-509.
36. Ławniczak M, Starzyńska T. Helicobacter pylori CagA(+) infectin in gastric cancer patients. Pol Merkur Lekarski 2002; 75: 216-220.
37. Mitchell HM, Hazell SL, LiYY, Hu PJ. Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterl 1996; 91: 1785-1788.
38. Abasiyanik MF, Sander E, Salih BA. Helicobacter pylori anti CagA antibodies: Prevalence in symptomatic and asymptomatic subjects in Turkey. Can J Gastroenterol 2002; 16: 527-532.
39. Nishiya D, Shimoyama T, Yoshimura T, Tanaka M, Fukuda S, Munakata A. Genes inside Cag PAI of Helicobacter pylori are not associated with gastric cancer in Japan. Hepatogastroenterology 2004; 51:891.
40. Zhou J, Zhang J, Xu C, He L. CagA genotype and variants in Chinese Helicobacter pylori strains, and relationship to gastroduodenal disease. J Med Microbiol 2004; 53: 231-235.